Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Neighbourly Pharmacy Inc T.NBLY.R


Primary Symbol: T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Comment by Kanatainvestoron Oct 21, 2023 1:43pm
101 Views
Post# 35694628

RE:RE:The trading action affirms the need for NBLY to go private

RE:RE:The trading action affirms the need for NBLY to go privateThanks for the comment. In my experience, deals done by financial buyers such as PCP tend to trade at a larger discount, but I would say we are currently at the upper end of that discount. In terms of the shareholder vote, already more than 10% of the non-PCP shared traded since the deal was announced, these are mostly arbitrage buyers who will certainly back the deal. Having said that, I do think there is scope for PCP to up the offer to the mid-range of TD's fair assessment to ensure a positive outcome at the shareholder meeting. The good news is that we don't have to wait too long, all this will play out in the next two to three weeks.
<< Previous
Bullboard Posts
Next >>